These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Change of PCDF and PCB concentrations in the blood of Yucheng and Yusho patients for 25 years]. Masuda Y, Haraguchi K, Kuroki H, Ryan JJ. Fukuoka Igaku Zasshi; 1995 May; 86(5):178-83. PubMed ID: 7628805 [Abstract] [Full Text] [Related]
5. Association of clinical findings in Yusho patients with serum concentrations of polychlorinated biphenyls, polychlorinated quarterphenyls and 2,3,4,7,8-pentachlorodibenzofuran more than 30 years after the poisoning event. Kanagawa Y, Matsumoto S, Koike S, Tajima B, Fukiwake N, Shibata S, Uchi H, Furue M, Imamura T. Environ Health; 2008 Oct 02; 7():47. PubMed ID: 18831733 [Abstract] [Full Text] [Related]
6. [Impaired mitogen-induced lymphocyte transformation in patients with Yusho]. Tsuji H, Ito Y. Fukuoka Igaku Zasshi; 2011 Apr 02; 102(4):81-6. PubMed ID: 21706884 [Abstract] [Full Text] [Related]
7. Elimination of polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs) from human blood in the Yusho and Yu-Cheng rice oil poisonings. Ryan JJ, Levesque D, Panopio LG, Sun WF, Masuda Y, Kuroki H. Arch Environ Contam Toxicol; 1993 May 02; 24(4):504-12. PubMed ID: 8507107 [Abstract] [Full Text] [Related]
9. [Levels of PCDDs, PCDFs and coplanar PCBs in sebum and blood of Yusho patients]. Iida T, Hirakawa H, Matsueda T, Hori T, Nakao T, Nakayama J. Fukuoka Igaku Zasshi; 1997 May 02; 88(5):177-85. PubMed ID: 9194338 [Abstract] [Full Text] [Related]
10. [Toxic effects and pharmacodynamics of PCB and PCDF in Yusho patients during the last 35 years]. Mstsuda Y, Haraguchi K. Fukuoka Igaku Zasshi; 2005 May 02; 96(5):113-23. PubMed ID: 15997762 [No Abstract] [Full Text] [Related]
11. [Steps for establishment of the diagnostic standard in Yusho patients]. Furue M, Uenotsuchi T. Fukuoka Igaku Zasshi; 2005 May 02; 96(5):124-34. PubMed ID: 15997763 [No Abstract] [Full Text] [Related]
12. PCB and PCDF congeners in the blood and tissues of yusho and yu-cheng patients. Masuda Y, Kuroki H, Haraguchi K, Nagayama J. Environ Health Perspect; 1985 Feb 02; 59():53-8. PubMed ID: 3921365 [Abstract] [Full Text] [Related]
14. Relationship between clinical features and blood levels of pentachlorodibenzofuran in patients with Yusho. Imamura T, Kanagawa Y, Matsumoto S, Tajima B, Uenotsuchi T, Shibata S, Furue M. Environ Toxicol; 2007 Apr 02; 22(2):124-31. PubMed ID: 17366567 [Abstract] [Full Text] [Related]
16. Causal agents of yusho. Kunita N, Kashimoto T, Miyata H, Fukushima S, Hori S, Obana H. Prog Clin Biol Res; 1984 Apr 02; 137():45-58. PubMed ID: 6425853 [Abstract] [Full Text] [Related]
17. Concentrations of PCBs, PCDFs and PCDDs in the blood of Yusho patients and their toxic equivalent contribution. Masuda Y, Schecter A, Päpke O. Chemosphere; 1998 Apr 02; 37(9-12):1773-80. PubMed ID: 9828305 [Abstract] [Full Text] [Related]
18. [Decreased serum aldolase levels in Yusho]. Yoshimura T, Nakano J, Kataoka H. Fukuoka Igaku Zasshi; 2007 May 02; 98(5):143-8. PubMed ID: 17642289 [Abstract] [Full Text] [Related]
19. Polychlorinated biphenyls and dibenzofurans in patients with yusho and their toxicological significance: a review. Masuda Y, Yoshimura H. Am J Ind Med; 1984 May 02; 5(1-2):31-44. PubMed ID: 6422748 [Abstract] [Full Text] [Related]